These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 6142567

  • 1. [Significance of laboratory chemical parameters for the detection of metastases in breast cancer].
    Pirich K, Graninger W, Schneeweiss B, Schuster R, Lenzhofer R, Gabl F.
    Wien Klin Wochenschr; 1983 Nov 25; 95(22):778-81. PubMed ID: 6142567
    [Abstract] [Full Text] [Related]

  • 2. A prospective study of current diagnostic procedures for assessment of hepatic metastases in colorectal cancers.
    Arnaud JP, Thibaud D, Leguillou A, Bergamaschi R, Adloff M.
    Eur J Surg Oncol; 1987 Aug 25; 13(4):355-8. PubMed ID: 2887457
    [Abstract] [Full Text] [Related]

  • 3. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C, Stieber P, Untch M, Nagel D, Eiermann W, Fateh-Moghadam A.
    Anticancer Res; 1998 Aug 25; 18(2B):1243-9. PubMed ID: 9615795
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.
    Kopp R, Classen S, Wolf H, Gholam P, Possinger K, Wilmanns W.
    Anticancer Res; 2001 Aug 25; 21(4B):2995-3000. PubMed ID: 11712800
    [Abstract] [Full Text] [Related]

  • 8. Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL-6)?
    Wechsel HW, Feil G, Lahme S, Zumbragel A, Petri E, Bichler KH.
    Anticancer Res; 1999 Aug 25; 19(4A):2577-81. PubMed ID: 10470198
    [Abstract] [Full Text] [Related]

  • 9. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
    Kurebayashi J, Nomura T, Hirono M, Okubo S, Udagawa K, Shiiki S, Ikeda M, Nakashima K, Tanaka K, Sonoo H.
    Jpn J Clin Oncol; 2006 Mar 25; 36(3):150-3. PubMed ID: 16520359
    [Abstract] [Full Text] [Related]

  • 10. Early diagnosis of breast cancer dissemination by tumor markers follow-up and method of prediction.
    Nekulová M, Simícková M, Pecen L, Eben K, Vermousek I, Stratil P, Cernoch M, Lang B.
    Neoplasma; 1994 Mar 25; 41(2):113-8. PubMed ID: 8208314
    [Abstract] [Full Text] [Related]

  • 11. [Check up of breast cancer stages 1 and 2].
    Gundersen S, Kvaløy S, Hannisdal E.
    Tidsskr Nor Laegeforen; 1997 Mar 20; 117(8):1079-81. PubMed ID: 9148472
    [Abstract] [Full Text] [Related]

  • 12. Serum ostase in the follow-up of breast cancer patients.
    Marchei P, Santini D, Bianco V, Chiodini S, Reale MG, Simeoni F, Marchei GG, Vecchione A.
    Anticancer Res; 1995 Mar 20; 15(5B):2217-22. PubMed ID: 8572628
    [Abstract] [Full Text] [Related]

  • 13. [What value should be given to assays of serum ferritin in breast cancers? Correlation with various biological parameters].
    Dalifard I, Daver A, Cellier P, Larra F.
    Sem Hop; 1984 Jan 26; 60(3):157-62. PubMed ID: 6320439
    [Abstract] [Full Text] [Related]

  • 14. [Diagnostic value of 4 biological markers: lactate dehydrogenase, phosphoglucoisomerase, carcinoembryonic antigen and gammaglutamyl transpeptidase, systematically determined in patients in a hematology-oncology department].
    Taillan B, Barthelemy G, Routy JP, Pedinielli FJ, Zarrouk F, Chardon H, Blanc AP.
    Pathol Biol (Paris); 1987 Apr 26; 35(4):375-80. PubMed ID: 2884616
    [Abstract] [Full Text] [Related]

  • 15. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
    Renner H, van Kampen M.
    Strahlenther Onkol; 1994 Aug 26; 170(8):441-52. PubMed ID: 8085210
    [Abstract] [Full Text] [Related]

  • 16. Significance of serum tumor markers in patients with carcinoma of the ovary.
    Kikuchi Y, Kizawa I, Koyama E, Kato K.
    Obstet Gynecol; 1984 Apr 26; 63(4):561-6. PubMed ID: 6199705
    [Abstract] [Full Text] [Related]

  • 17. Breast cancer and neoadjuvant therapy: any predictive marker?
    Vyzula R, Dusek L, Zaloudík J, Demlová R, Klimes D, Selvekerová S.
    Neoplasma; 2004 Apr 26; 51(6):471-80. PubMed ID: 15640958
    [Abstract] [Full Text] [Related]

  • 18. [Value of locoregional chemotherapy in liver metastases of breast carcinoma].
    Zimmermann T, Flechsenhar K, Padberg W.
    Zentralbl Chir; 1998 Apr 26; 123 Suppl 5():159-61. PubMed ID: 10063604
    [Abstract] [Full Text] [Related]

  • 19. Cardiac hepatopathy before and after heart transplantation.
    Dichtl W, Vogel W, Dunst KM, Grander W, Alber HF, Frick M, Antretter H, Laufer G, Pachinger O, Pölzl G.
    Transpl Int; 2005 Jun 26; 18(6):697-702. PubMed ID: 15910296
    [Abstract] [Full Text] [Related]

  • 20. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
    al-Jarallah MA, Behbehani AE, el-Nass SA, Temim L, Ebraheem AK, Ali MA, Szymendera JJ.
    Eur J Surg Oncol; 1993 Feb 26; 19(1):74-9. PubMed ID: 8436243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.